| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |